GOLDMAN SACHS GROUP INC - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2022$5,120
-81.7%
14,221
-42.3%
0.00%
Q4 2021$28,000
-46.2%
24,629
-15.8%
0.00%
Q3 2021$52,000
-96.2%
29,235
-92.9%
0.00%
Q2 2021$1,360,000
-0.4%
412,257
+1.2%
0.00%
Q1 2021$1,365,000407,4640.00%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,554,925$2,750,0000.42%
SABBY MANAGEMENT, LLC 900,000$446,0000.30%
Sio Capital Management, LLC 1,270,758$629,0000.24%
Vivo Capital, LLC 2,840,909$1,406,0000.14%
Waterfront Wealth Inc. 353,000$175,0000.07%
DAFNA Capital Management LLC 343,720$170,0000.05%
RTW INVESTMENTS, LP 3,250,000$1,609,0000.04%
Ikarian Capital, LLC 970,747$185,0000.03%
MYDA Advisors LLC 150,000$74,0000.02%
Temasek Holdings (Private) Ltd 1,678,075$830,6470.01%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders